Kevin Peterson

Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias

Judith E. Karp, B M Thomas, Jacqueline M. Greer et al. · Clinical Cancer Research · 2012 · 117 citations · Full text

Medicine, Oncology, Pharmacology +17

Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant Variants

Sabelle Jallow, Abraham Alabi, Ramu Sarge‐Njie et al. · Journal of Clinical Microbiology · 2009 · 66 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

The concentrations and distributions of phytic acid phosphorus and other mineral nutrients in wild-type and <i>low phytic acid</i> Js-12-LPA wheat (<i>Triticum aestivum</i>) grain parts

Charlie Joyce, Andrea Deneau, Kevin Peterson et al. · Canadian Journal of Botany · 2005 · 45 citations

Agriculture, Crop Sciences, Plant Sciences +17

A Substantial Fraction of Barley (Hordeum vulgare L.) Low Phytic Acid Mutations Have Little or No Effect on Yield across Diverse Production Environments

Victor Raboy, Kevin Peterson, Chad Jackson et al. · Plants · 2015 · 44 citations · Full text

Agriculture, Crop Sciences, Plant Sciences +14

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Thomas E. Witzig, Hui Tang, Ivana N. Micallef et al. · Blood · 2011 · 44 citations · Full text

Medicine, Oncology, Pharmacology +10